Patterns of Insulin Secretion During First-Phase Insulin Secretion in Normal Chinese Adults

The increase in diabetes worldwide is alarming. Decreased acute insulin response to intravenous glucose tolerance test (IVGTT) during first-phase insulin secretion (FPIS) is a characteristic of diabetes. However, knowledge of the insulin secretion characteristics identified by different time to gluc...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 12; p. 738427
Main Authors Yuan, Tao, Song, Shuoning, Zhao, Tianyi, Duo, Yanbei, Wang, Shihan, Gao, Junxiang, Liu, Shixuan, Dong, Yingyue, Li, Rui, Fu, Yong, Zhao, Weigang
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 17.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The increase in diabetes worldwide is alarming. Decreased acute insulin response to intravenous glucose tolerance test (IVGTT) during first-phase insulin secretion (FPIS) is a characteristic of diabetes. However, knowledge of the insulin secretion characteristics identified by different time to glucose peak in subjects with different metabolic state is sparse. This study aimed to find different patterns of FPIS in subjects with normal glucose tolerance (NGT) and analyzed the relationship between insulin secretion patterns and the risk for development of type 2 diabetes mellitus (T2DM). A total of 126 subjects were divided into three groups during a 10-min IVGTT, including NGT with time to glucose peak after 3 min (G1, n = 21), NGT with time to glucose peak at 3 min (G2, n = 95), and prediabetes or diabetes with time to glucose peak at 3 min (G3, n = 10). Glucose, insulin, and C-peptide concentrations at 0, 3, 5, 7, and 10 min during the IVGTT were tested. IVGTT-based indices were calculated to evaluate the insulin secretion and insulin sensitivity. Age, body mass index (BMI), waist-to-hip ratio, triglyceride (TG), and hemoglobin A1c (HbA1c) of subjects were gradually higher, while high-density lipoprotein cholesterol (HDL-C) was gradually lower from G1 to G3 ( for linear trend <0.05), and the differences between G1 and G2 were also statistically significant ( < 0.05). Glucose peak of most participants in G1 converged at 5 min, and the curves shape of insulin and C-peptide in G2 were the sharpest among three groups. There was no significant difference in all IVGTT-based indices between G1 and G2, but AUC , AUC /AUC , and △Ins /△Glu in G2 were the highest, and the value for linear trend of those indices among three groups were statistically significant ( < 0.05). Two patterns of FPIS were in subjects with NGT, while subjects with later time to glucose peak during FPIS might be less likely to develop T2DM in the future.
AbstractList BackgroundThe increase in diabetes worldwide is alarming. Decreased acute insulin response to intravenous glucose tolerance test (IVGTT) during first-phase insulin secretion (FPIS) is a characteristic of diabetes. However, knowledge of the insulin secretion characteristics identified by different time to glucose peak in subjects with different metabolic state is sparse.AimsThis study aimed to find different patterns of FPIS in subjects with normal glucose tolerance (NGT) and analyzed the relationship between insulin secretion patterns and the risk for development of type 2 diabetes mellitus (T2DM).MethodsA total of 126 subjects were divided into three groups during a 10-min IVGTT, including NGT with time to glucose peak after 3 min (G1, n = 21), NGT with time to glucose peak at 3 min (G2, n = 95), and prediabetes or diabetes with time to glucose peak at 3 min (G3, n = 10). Glucose, insulin, and C-peptide concentrations at 0, 3, 5, 7, and 10 min during the IVGTT were tested. IVGTT-based indices were calculated to evaluate the insulin secretion and insulin sensitivity.ResultsAge, body mass index (BMI), waist-to-hip ratio, triglyceride (TG), and hemoglobin A1c (HbA1c) of subjects were gradually higher, while high-density lipoprotein cholesterol (HDL-C) was gradually lower from G1 to G3 (p for linear trend <0.05), and the differences between G1 and G2 were also statistically significant (p < 0.05). Glucose peak of most participants in G1 converged at 5 min, and the curves shape of insulin and C-peptide in G2 were the sharpest among three groups. There was no significant difference in all IVGTT-based indices between G1 and G2, but AUCIns, AUCIns/AUCGlu, and △Ins3/△Glu3 in G2 were the highest, and the p-value for linear trend of those indices among three groups were statistically significant (p < 0.05).ConclusionsTwo patterns of FPIS were in subjects with NGT, while subjects with later time to glucose peak during FPIS might be less likely to develop T2DM in the future.
The increase in diabetes worldwide is alarming. Decreased acute insulin response to intravenous glucose tolerance test (IVGTT) during first-phase insulin secretion (FPIS) is a characteristic of diabetes. However, knowledge of the insulin secretion characteristics identified by different time to glucose peak in subjects with different metabolic state is sparse.BackgroundThe increase in diabetes worldwide is alarming. Decreased acute insulin response to intravenous glucose tolerance test (IVGTT) during first-phase insulin secretion (FPIS) is a characteristic of diabetes. However, knowledge of the insulin secretion characteristics identified by different time to glucose peak in subjects with different metabolic state is sparse.This study aimed to find different patterns of FPIS in subjects with normal glucose tolerance (NGT) and analyzed the relationship between insulin secretion patterns and the risk for development of type 2 diabetes mellitus (T2DM).AimsThis study aimed to find different patterns of FPIS in subjects with normal glucose tolerance (NGT) and analyzed the relationship between insulin secretion patterns and the risk for development of type 2 diabetes mellitus (T2DM).A total of 126 subjects were divided into three groups during a 10-min IVGTT, including NGT with time to glucose peak after 3 min (G1, n = 21), NGT with time to glucose peak at 3 min (G2, n = 95), and prediabetes or diabetes with time to glucose peak at 3 min (G3, n = 10). Glucose, insulin, and C-peptide concentrations at 0, 3, 5, 7, and 10 min during the IVGTT were tested. IVGTT-based indices were calculated to evaluate the insulin secretion and insulin sensitivity.MethodsA total of 126 subjects were divided into three groups during a 10-min IVGTT, including NGT with time to glucose peak after 3 min (G1, n = 21), NGT with time to glucose peak at 3 min (G2, n = 95), and prediabetes or diabetes with time to glucose peak at 3 min (G3, n = 10). Glucose, insulin, and C-peptide concentrations at 0, 3, 5, 7, and 10 min during the IVGTT were tested. IVGTT-based indices were calculated to evaluate the insulin secretion and insulin sensitivity.Age, body mass index (BMI), waist-to-hip ratio, triglyceride (TG), and hemoglobin A1c (HbA1c) of subjects were gradually higher, while high-density lipoprotein cholesterol (HDL-C) was gradually lower from G1 to G3 (p for linear trend <0.05), and the differences between G1 and G2 were also statistically significant (p < 0.05). Glucose peak of most participants in G1 converged at 5 min, and the curves shape of insulin and C-peptide in G2 were the sharpest among three groups. There was no significant difference in all IVGTT-based indices between G1 and G2, but AUCIns, AUCIns/AUCGlu, and △Ins3/△Glu3 in G2 were the highest, and the p-value for linear trend of those indices among three groups were statistically significant (p < 0.05).ResultsAge, body mass index (BMI), waist-to-hip ratio, triglyceride (TG), and hemoglobin A1c (HbA1c) of subjects were gradually higher, while high-density lipoprotein cholesterol (HDL-C) was gradually lower from G1 to G3 (p for linear trend <0.05), and the differences between G1 and G2 were also statistically significant (p < 0.05). Glucose peak of most participants in G1 converged at 5 min, and the curves shape of insulin and C-peptide in G2 were the sharpest among three groups. There was no significant difference in all IVGTT-based indices between G1 and G2, but AUCIns, AUCIns/AUCGlu, and △Ins3/△Glu3 in G2 were the highest, and the p-value for linear trend of those indices among three groups were statistically significant (p < 0.05).Two patterns of FPIS were in subjects with NGT, while subjects with later time to glucose peak during FPIS might be less likely to develop T2DM in the future.ConclusionsTwo patterns of FPIS were in subjects with NGT, while subjects with later time to glucose peak during FPIS might be less likely to develop T2DM in the future.
The increase in diabetes worldwide is alarming. Decreased acute insulin response to intravenous glucose tolerance test (IVGTT) during first-phase insulin secretion (FPIS) is a characteristic of diabetes. However, knowledge of the insulin secretion characteristics identified by different time to glucose peak in subjects with different metabolic state is sparse. This study aimed to find different patterns of FPIS in subjects with normal glucose tolerance (NGT) and analyzed the relationship between insulin secretion patterns and the risk for development of type 2 diabetes mellitus (T2DM). A total of 126 subjects were divided into three groups during a 10-min IVGTT, including NGT with time to glucose peak after 3 min (G1, n = 21), NGT with time to glucose peak at 3 min (G2, n = 95), and prediabetes or diabetes with time to glucose peak at 3 min (G3, n = 10). Glucose, insulin, and C-peptide concentrations at 0, 3, 5, 7, and 10 min during the IVGTT were tested. IVGTT-based indices were calculated to evaluate the insulin secretion and insulin sensitivity. Age, body mass index (BMI), waist-to-hip ratio, triglyceride (TG), and hemoglobin A1c (HbA1c) of subjects were gradually higher, while high-density lipoprotein cholesterol (HDL-C) was gradually lower from G1 to G3 ( for linear trend <0.05), and the differences between G1 and G2 were also statistically significant ( < 0.05). Glucose peak of most participants in G1 converged at 5 min, and the curves shape of insulin and C-peptide in G2 were the sharpest among three groups. There was no significant difference in all IVGTT-based indices between G1 and G2, but AUC , AUC /AUC , and △Ins /△Glu in G2 were the highest, and the value for linear trend of those indices among three groups were statistically significant ( < 0.05). Two patterns of FPIS were in subjects with NGT, while subjects with later time to glucose peak during FPIS might be less likely to develop T2DM in the future.
Author Gao, Junxiang
Song, Shuoning
Liu, Shixuan
Duo, Yanbei
Yuan, Tao
Zhao, Tianyi
Li, Rui
Dong, Yingyue
Zhao, Weigang
Wang, Shihan
Fu, Yong
AuthorAffiliation Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China
AuthorAffiliation_xml – name: Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China
Author_xml – sequence: 1
  givenname: Tao
  surname: Yuan
  fullname: Yuan, Tao
– sequence: 2
  givenname: Shuoning
  surname: Song
  fullname: Song, Shuoning
– sequence: 3
  givenname: Tianyi
  surname: Zhao
  fullname: Zhao, Tianyi
– sequence: 4
  givenname: Yanbei
  surname: Duo
  fullname: Duo, Yanbei
– sequence: 5
  givenname: Shihan
  surname: Wang
  fullname: Wang, Shihan
– sequence: 6
  givenname: Junxiang
  surname: Gao
  fullname: Gao, Junxiang
– sequence: 7
  givenname: Shixuan
  surname: Liu
  fullname: Liu, Shixuan
– sequence: 8
  givenname: Yingyue
  surname: Dong
  fullname: Dong, Yingyue
– sequence: 9
  givenname: Rui
  surname: Li
  fullname: Li, Rui
– sequence: 10
  givenname: Yong
  surname: Fu
  fullname: Fu, Yong
– sequence: 11
  givenname: Weigang
  surname: Zhao
  fullname: Zhao, Weigang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34867781$$D View this record in MEDLINE/PubMed
BookMark eNp1kktvEzEUhS1UREvpD2CDZskmwa_xY4NUBQqRKqgErFhYftxJXE3sYs8g8e9xmha1CLyxr33Od2X7PEdHKSdA6CXBS8aUfjNACnlJMSVLyRSn8gk6IULwBWWaHj1YH6OzWq9xGxwTrdUzdMy4ElIqcoK-X9lpgpJql4duneo8xtR9AV9gijl17-YS06a7iKVOi6utrfAPUSs-5bKzY7faxgRNcx7mcaov0NPBjhXO7uZT9O3i_dfVx8Xl5w_r1fnlwnPRTwsSBiUYBNlTqbwTXHvhcSCeY-sspj33LCinA2Dh-jBwRhUHSsBpZwmV7BStD9yQ7bW5KXFnyy-TbTS3G7lsjC1T9CMYIYbgseq91o5bIhRXwAfRg-OUOtk31tsD62Z2Owge0lTs-Aj6-CTFrdnkn6ZdoZeaN8DrO0DJP2aok9nF6mEcbYI8V0MFlgxzykmTvnrY60-T-99pAnkQ-JJrLTAYHye7f_PWOo6GYLOPgrmNgtlHwRyi0JzkL-c9_P-e32CEuJs
CitedBy_id crossref_primary_10_3389_fnut_2024_1469230
crossref_primary_10_1007_s11695_023_06857_z
crossref_primary_10_3389_fnut_2022_977278
Cites_doi 10.1002/dmrr.198
10.1007/s00125-003-1153-1
10.1016/j.cmet.2017.12.017
10.2337/dc08-s264
10.1152/ajpendo.00251.2015
10.3390/ijms21176275
10.1007/s12020-007-0002-2
10.1210/jc.2005-1093
10.1016/s0140-6736(73)90599-0
10.1007/s12020-008-9106-6
10.2337/db11-1516
10.1177/000992289803700204
10.1016/j.diabres.2019.107843
10.2337/dc18-0279
10.1001/jama.283.17.2253
10.1007/s00018-020-03688-4
10.2337/dc09-1115
10.1172/jci.insight.124912
10.2337/dc12-1235
10.2337/diabetes.51.2007.s117
10.1111/dme.13055
10.1210/clinem/dgaa234
10.1152/ajpendo.00380.2018
10.1210/jcem.75.1.1619033
ContentType Journal Article
Copyright Copyright © 2021 Yuan, Song, Zhao, Duo, Wang, Gao, Liu, Dong, Li, Fu and Zhao.
Copyright © 2021 Yuan, Song, Zhao, Duo, Wang, Gao, Liu, Dong, Li, Fu and Zhao 2021 Yuan, Song, Zhao, Duo, Wang, Gao, Liu, Dong, Li, Fu and Zhao
Copyright_xml – notice: Copyright © 2021 Yuan, Song, Zhao, Duo, Wang, Gao, Liu, Dong, Li, Fu and Zhao.
– notice: Copyright © 2021 Yuan, Song, Zhao, Duo, Wang, Gao, Liu, Dong, Li, Fu and Zhao 2021 Yuan, Song, Zhao, Duo, Wang, Gao, Liu, Dong, Li, Fu and Zhao
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fendo.2021.738427
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2392
ExternalDocumentID oai_doaj_org_article_66fdc085c99b4a16848e4f65eb422b75
PMC8635794
34867781
10_3389_fendo_2021_738427
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
CGR
CUY
CVF
ECM
EIF
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c465t-1df863ed75278cb649c6c0d1c40aba0254c3d8b9de06b5df43284e21eb9ba1273
IEDL.DBID M48
ISSN 1664-2392
IngestDate Wed Aug 27 01:25:44 EDT 2025
Thu Aug 21 18:22:34 EDT 2025
Thu Jul 10 23:36:40 EDT 2025
Thu Jan 02 22:55:13 EST 2025
Tue Jul 01 04:27:48 EDT 2025
Thu Apr 24 23:00:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords type 2 diabetes mellitus
first-phase insulin secretion
insulin sensitivity
normal glucose tolerance
intravenous glucose tolerance test
Language English
License Copyright © 2021 Yuan, Song, Zhao, Duo, Wang, Gao, Liu, Dong, Li, Fu and Zhao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-1df863ed75278cb649c6c0d1c40aba0254c3d8b9de06b5df43284e21eb9ba1273
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Maria Perticone, University of Magna Graecia, Italy
These authors have contributed equally to this work and share first authorship
This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology
Reviewed by: Aaron Hanukoglu, Tel Aviv University, Israel; David H. Wagner, University of Colorado Denver, United States
OpenAccessLink https://doaj.org/article/66fdc085c99b4a16848e4f65eb422b75
PMID 34867781
PQID 2607304241
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_66fdc085c99b4a16848e4f65eb422b75
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8635794
proquest_miscellaneous_2607304241
pubmed_primary_34867781
crossref_citationtrail_10_3389_fendo_2021_738427
crossref_primary_10_3389_fendo_2021_738427
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-11-17
PublicationDateYYYYMMDD 2021-11-17
PublicationDate_xml – month: 11
  year: 2021
  text: 2021-11-17
  day: 17
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in endocrinology (Lausanne)
PublicationTitleAlternate Front Endocrinol (Lausanne)
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Del Prato (B4) 2001; 17
Saeedi (B1) 2019; 157
Pedersen (B3) 2019; 316
Omar-Hmeadi (B8) 2021; 78
Henquin (B10) 2015; 309
Kim (B7) 2016; 33
Gandasi (B13) 2018; 27
Shanik (B18) 2008
Galicia-Garcia (B2) 2020; 21
Cerasi (B11) 1973; 1
Tricò (B19) 2018; 3
Fehse (B5) 2005; 90
Hong (B14) 2007; 31
Osei (B17) 1992; 75
Gerich (B9) 2002
Rorsman (B22) 2003; 46
Brancati (B24) 2000; 283
Lorenzo (B15) 2010; 33
Hong (B23) 2008; 34
Hulman (B6) 2018; 41
Rosengren (B12) 2012; 61
Arslanian (B16) 1998; 37
Armiyaw (B20) 2020; 105
Kodama (B21) 2013; 36
References_xml – volume: 17
  year: 2001
  ident: B4
  article-title: The Importance of First-Phase Insulin Secretion: Implications for the Therapy of Type 2 Diabetes Mellitus
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.198
– volume: 46
  year: 2003
  ident: B22
  article-title: Insulin Granule Dynamics in Pancreatic Beta Cells
  publication-title: Diabetologia
  doi: 10.1007/s00125-003-1153-1
– volume: 27
  start-page: 470
  year: 2018
  ident: B13
  article-title: Glucose-Dependent Granule Docking Limits Insulin Secretion and Is Decreased in Human Type 2 Diabetes
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.12.017
– year: 2008
  ident: B18
  article-title: Insulin Resistance and Hyperinsulinemia: Is Hyperinsulinemia the Cart or the Horse
  publication-title: Diabetes Care
  doi: 10.2337/dc08-s264
– volume: 309
  year: 2015
  ident: B10
  article-title: Dynamics of Glucose-Induced Insulin Secretion in Normal Human Islets
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00251.2015
– volume: 21
  start-page: 6275
  year: 2020
  ident: B2
  article-title: Pathophysiology of Type 2 Diabetes Mellitus
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21176275
– volume: 31
  year: 2007
  ident: B14
  article-title: The Interplay of Insulin Resistance and Beta-Cell Dysfunction Involves the Development of Type 2 Diabetes in Chinese Obeses
  publication-title: Endocrine
  doi: 10.1007/s12020-007-0002-2
– volume: 90
  year: 2005
  ident: B5
  article-title: Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects With Type 2 Diabetes
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1093
– volume: 1
  year: 1973
  ident: B11
  article-title: Dose-Response Relation Between Plasma-Insulin and Blood-Glucose Levels During Oral Glucose Loads in Prediabetic and Diabetic Subjects
  publication-title: Lancet
  doi: 10.1016/s0140-6736(73)90599-0
– volume: 34
  start-page: 75
  year: 2008
  ident: B23
  article-title: Insulin Sensitivity and First-Phase Insulin Secretion in Obese Chinese With Hyperglycemia in 30 and/or 60 Min During Glucose Tolerance Tests
  publication-title: Endocrine
  doi: 10.1007/s12020-008-9106-6
– volume: 61
  year: 2012
  ident: B12
  article-title: Reduced Insulin Exocytosis in Human Pancreatic β-Cells With Gene Variants Linked to Type 2 Diabetes
  publication-title: Diabetes
  doi: 10.2337/db11-1516
– volume: 37
  year: 1998
  ident: B16
  article-title: Insulin Secretion and Sensitivity in Healthy African-American vs American White Children
  publication-title: Clin Pediatr (Phila)
  doi: 10.1177/000992289803700204
– volume: 157
  year: 2019
  ident: B1
  article-title: Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results From the International Diabetes Federation Diabetes Atlas, 9(Th) Edition
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2019.107843
– volume: 41
  year: 2018
  ident: B6
  article-title: Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study
  publication-title: Diabetes Care
  doi: 10.2337/dc18-0279
– volume: 283
  year: 2000
  ident: B24
  article-title: Incident Type 2 Diabetes Mellitus in African American and White Adults: The Atherosclerosis Risk in Communities Study
  publication-title: JAMA
  doi: 10.1001/jama.283.17.2253
– volume: 78
  year: 2021
  ident: B8
  article-title: Insulin Granule Biogenesis and Exocytosis
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-020-03688-4
– volume: 33
  start-page: 67
  year: 2010
  ident: B15
  article-title: Insulin Resistance, Beta-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population: The Insulin Resistance Atherosclerosis Study
  publication-title: Diabetes Care
  doi: 10.2337/dc09-1115
– volume: 3
  year: 2018
  ident: B19
  article-title: Identification, Pathophysiology, and Clinical Implications of Primary Insulin Hypersecretion in Nondiabetic Adults and Adolescents
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.124912
– volume: 36
  year: 2013
  ident: B21
  article-title: Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response: A Systematic Review and Meta-Analysis
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1235
– year: 2002
  ident: B9
  article-title: Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.2007.s117
– volume: 33
  year: 2016
  ident: B7
  article-title: Relationship Between Insulin Sensitivity and Insulin Secretion Rate: Not Necessarily Hyperbolic
  publication-title: Diabetes Med
  doi: 10.1111/dme.13055
– volume: 105
  year: 2020
  ident: B20
  article-title: Increased β-Cell Responsivity Independent of Insulin Sensitivity in Healthy African American Adults
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgaa234
– volume: 316
  year: 2019
  ident: B3
  article-title: Calcium Signaling and Secretory Granule Pool Dynamics Underlie Biphasic Insulin Secretion and its Amplification by Glucose: Experiments and Modeling
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00380.2018
– volume: 75
  year: 1992
  ident: B17
  article-title: Differences in Basal and Poststimulation Glucose Homeostasis in Nondiabetic First Degree Relatives of Black and White Patients With Type 2 Diabetes Mellitus
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.75.1.1619033
SSID ssj0000401998
Score 2.2684026
Snippet The increase in diabetes worldwide is alarming. Decreased acute insulin response to intravenous glucose tolerance test (IVGTT) during first-phase insulin...
BackgroundThe increase in diabetes worldwide is alarming. Decreased acute insulin response to intravenous glucose tolerance test (IVGTT) during first-phase...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 738427
SubjectTerms Adult
Blood Glucose - analysis
China
Diabetes Mellitus, Type 2 - blood
Endocrinology
Female
first-phase insulin secretion
Glucose Tolerance Test
Humans
Insulin Resistance - physiology
Insulin Secretion - physiology
insulin sensitivity
intravenous glucose tolerance test
Male
Middle Aged
normal glucose tolerance
Prediabetic State - blood
Risk Assessment
type 2 diabetes mellitus
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS-RAEG4WD7IXWXUfs-oSwdNC1nS60o-jjx1UUAQVhD00_QoKkpGd8f9b1YnDzCLrxWOSCmm-rqS-Snd9xdherJwRyJRLF6QsofaxdNrwsk6t0FDz4HKF9_mFPLmBs9vmdqHVF-0J6-WBe-D2pWxjQF4QjPHguNSgE7SySR7q2qusXooxbyGZyt9gTBswkeiXMTELM_tt6iIV-9X8l6JRqKVAlPX6XyOZ_-6VXAg-409sbWCNxUE_2nX2IXUbbPV8WBffZH8us0xmNy0mbXHaby8vrogREu7Fca5FLMb3SPXKyzsMXK8Y4cEFEdiHgnpqJ7Q5IG2O6Wd2M_59fXRSDm0TygCymZU8tlqKFFVTKx28BBNkqCIPUDnvqPo9iKi9iamSvoktCAxRqebJG-840pkvbKWbdOkbKxqvIYokVIQAjRKG6yQhtRK0D943I1a9YGjDoClOrS0eLOYWBLvNsFuC3fawj9jP-S2PvaDG_4wPaWLmhqSFnU-gh9jBQ-xbHjJiuy_TavHdoQUR16XJ09RiLqfodw7wEfvaT_P8UYKkCJXGK2rJAZbGsnylu7_L-tyaNP4MfH-PwW-xj4QHVT9ytc1WZn-f0g7SoJn_kT3-GS0mBlg
  priority: 102
  providerName: Directory of Open Access Journals
Title Patterns of Insulin Secretion During First-Phase Insulin Secretion in Normal Chinese Adults
URI https://www.ncbi.nlm.nih.gov/pubmed/34867781
https://www.proquest.com/docview/2607304241
https://pubmed.ncbi.nlm.nih.gov/PMC8635794
https://doaj.org/article/66fdc085c99b4a16848e4f65eb422b75
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBddB2Mvo91n2q14sKeBOss66-NhjO4j6wYphS0Q2IOxPtwWgrMlKXT_fe9kJywjjL0YbMmWfCf5fif5fsfYq5DXViJS5rVXikPhAq-NFbyIjTRQCF-nCO_RmTodw9dJOdlhq_RWvQAXW107yic1nk-Pb379focT_i15nGhv3zSxDRTHV4hjTQ3oO-wuGiZN83TUo_30YUZfwqbsuEIp4AVCg26fc_tTNixVIvTfhkL__pnyD-s03GMPeliZnXTjYJ_txPYhuzfqN84fsR_niUezXWSzJvvS_X-efSPISIrJPqZgxWx4hViQn1-iZdtSCU_OCOFOM0q6HbHOCZF3LB6z8fDT9w-nvM-rwD2ocslFaIySMeiy0MY7BdYrnwfhIa9dTeHxXgbjbIi5cmVoQKINi4WIzrpaIN55wnbbWRufsax0BoKMUgfwUGpphYkKYqPAOO9cOWD5SoaV70nHKffFtELng8ReJbFXJPaqE_uAvV7f8rNj3PhX5fekmHVFIstOF2bzi6qfe5VSTfAILb21DmqhDJgIjSqjg6JwGjv5cqXWCicX7ZjUbZxdLyp09jSt94AYsKedmtdNSeIq1AZL9MYA2OjLZkl7dZkIvA2RAFo4-I92D9l9el2KfhT6Odtdzq_jC4RBS3eUlg_w-HkijtJAvwWdrQeS
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patterns+of+Insulin+Secretion+During+First-Phase+Insulin+Secretion+in+Normal+Chinese+Adults&rft.jtitle=Frontiers+in+endocrinology+%28Lausanne%29&rft.au=Yuan%2C+Tao&rft.au=Song%2C+Shuoning&rft.au=Zhao%2C+Tianyi&rft.au=Duo%2C+Yanbei&rft.date=2021-11-17&rft.issn=1664-2392&rft.eissn=1664-2392&rft.volume=12&rft.spage=738427&rft_id=info:doi/10.3389%2Ffendo.2021.738427&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2392&client=summon